Cuprina Holdings (Cayman) LTD (NASDAQ:CUPR) Short Interest Up 161.2% in June

Cuprina Holdings (Cayman) LTD (NASDAQ:CUPR) was the recipient of a large growth in short interest in the month of June. As of June 15th, there was short interest totaling 222,527 shares, a growth of 161.2% from the May 31st total of 85,189 shares. Based on an average daily volume of 12,012,243 shares, the short-interest ratio is presently 0.0 days. Currently, 24.2% of the company’s stock are sold short.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Cuprina Holdings (Cayman) in a report on Friday, April 24th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock has a consensus rating of “Sell”.

Cuprina Holdings (Cayman) Price Performance

Shares of CUPR stock opened at $5.33 on Monday. The company’s 50-day moving average is $2.96. Cuprina Holdings has a 1-year low of $1.76 and a 1-year high of $76.00. The company has a debt-to-equity ratio of 0.07, a quick ratio of 2.35 and a current ratio of 2.35.

Cuprina Holdings (Cayman) (NASDAQ:CUPR) last released its quarterly earnings results on Monday, April 27th. The company reported ($0.40) EPS for the quarter. The business had revenue of $0.01 million for the quarter.

Cuprina Holdings (Cayman) Company Profile

We are a Singapore-based biomedical and biotechnology company that is dedicated to the development and commercialization of innovative products for the management of chronic wounds, as well as operating in the health and beauty sectors. Our expertise in biomedical research allows us to identify and utilize materials derived from natural sources to develop wound care products in the form of medical devices which meet international standards. We believe we will be able to build upon and leverage such expertise to develop innovative cosmeceutical products in the future.